Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew John Partridge currently holds 163,738 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew John Partridge has been a net seller of TPTX stock. They have purchased $0 and sold $239.1K worth of shares.
Andrew John Partridge's most recent insider trade was on Jun 4, 2026, when they sold 1,491 shares at $61.08 per share.
Andrew John Partridge serves as Executive at Turning Point Therapeutics, Inc. (TPTX). They have executed 6 insider transactions totaling $239.1K over their tenure at the company.
Andrew John Partridge holds the position of Executive at Turning Point Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andrew John Partridge has shown a selling trading pattern, with $0 in total purchases and $239.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew John Partridge was on Jul 14, 2021, when they sold $140.0K worth of TPTX shares. This transaction involved 1,869 shares at $74.90 per share.
Andrew John Partridge currently owns 163,738 shares of Turning Point Therapeutics, Inc. (TPTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew John Partridge's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew John Partridge has 6 Form 4 filings on record as an insider at Turning Point Therapeutics, Inc..
Set alerts for Andrew John Partridge and 40,000+ other insiders.